ArticleDiscover oncology2025
Prognostic analysis and mechanistic exploration of the autophagy-related exosome genes ITGA3, ITGB4, and PTK6 in pancreatic ductal adenocarcinoma.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Role of PTK6 in the diagnosis, prognosis, and immune infiltration of pancreatic cancer based on evidence from bioinformatics analysis and experimental validation.Discover oncology · 2026Article
- Integrin β3: structural functions, tumour microenvironment regulatory roles and targeted intervention strategies.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Pancreatic cancer (PC) is a highly malignant tumor with an extremely poor prognosis, but early diagnosis and treatment can significantly improve prognosis. This study aimed to screen autophagy-related exosome genes associated with poor prognosis in PC and to explore the underlying mechanisms in malignant progression via bioinformatics analysis to provide a reference for the diagnosis, treatment and prognosis evaluation of PC, especially pancreatic ductal adenocarcinoma (PDAC). Matrix files of 178 PC tissues (including 143 PDAC) and 167 healthy human pancreatic tissues and clinical data were downloaded from the UCSC Xena database, exosome database (exoRbase) and autophagy database (HADb), and the relevant mechanisms were explored by bioinformatics methods, including differential analysis, LASSO regression analysis, survival analysis, functional analysis, immune infiltration analysis and drug sensitivity analysis. Finally, the expression of related genes in PDAC was verified via immunohistochemistry. Our research results indicate that the autophagy-related exosome genes PTK6, ITGA3 and ITGB4 are independent risk factors for PC and may promote PC development and invasion by promoting cell-cell adhesion and cell-matrix adhesion, inhibiting tumor cell autophagy, promoting nerve infiltration, reducing CD8 + T-cell content, and increasing M0 and M2 macrophage content. Drug susceptibility analysis showed that crizotinib, tamoxifen, ixazomib, and carboplatin had inhibitory effects on ITGA3, ITGB4, and PTK6.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.